Search research articles
Contact Us
Filters
Showing results (1051-1060 of 1,173) with videos related to
Page
of 118
Sort By:
Annals of Family Medicine
|
March 10, 2010
Patients' question-asking behavior during primary care visits: a report from the AAFP National Research Network
James M Galliher, Douglas M Post, Barry D Weiss, et al.
Plos One
|
June 19, 2015
Immunogens Modeling a Fusion-Intermediate Conformation of gp41 Elicit Antibodies to the Membrane Proximal External Region of the HIV Envelope Glycoprotein
Russell Vassell, Yong He, Prasad Vennakalanti, et al.
American Journal of Physical Medicine & Rehabilitation
|
October 15, 2019
The Vital Role of Professionalism in Physical Medicine and Rehabilitation
Julie K Silver, Sara Cuccurullo, Lyn D Weiss, et al.
Drug and Alcohol Dependence
|
April 12, 2008
Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders
Timothy E Wilens, Lenard A Adler, Margaret D Weiss, et al.
Metabolic Engineering
|
August 30, 2005
Metabolically engineered oilseed crops with enhanced seed tocopherol
Balasulojini Karunanandaa, Qungang Qi, Ming Hao, et al.
Plos One
|
April 5, 2022
Opioid-related overdose and chronic use following an initial prescription of hydrocodone versus oxycodone
Scott G Weiner, Michelle A Hendricks, Sanae El Ibrahimi, et al.
Leukemia
|
March 11, 2017
The CXCR4 inhibitor BL-8040 induces the apoptosis of AML blasts by downregulating ERK, BCL-2, MCL-1 and cyclin-D1 via altered miR-15a/16-1 expression
M Abraham, S Klein, B Bulvik, et al.
Psycho-Oncology
|
February 12, 2004
The talking touchscreen: a new approach to outcomes assessment in low literacy
Elizabeth A Hahn, David Cella, Deborah Dobrez, et al.
Journal of the American Academy of Child and Adolescent Psychiatry
|
August 23, 2007
High-dose atomoxetine treatment of ADHD in youths with limited response to standard doses
Christopher J Kratochvil, David Michelson, Jeffrey H Newcorn, et al.
Cancer Research
|
December 21, 2017
CXCR4 Promotes Neuroblastoma Growth and Therapeutic Resistance through miR-15a/16-1-Mediated ERK and BCL2/Cyclin D1 Pathways
Shiri Klein, Michal Abraham, Baruch Bulvik, et al.
Page
of 118
Search research articles
Search
Showing results (1051-1060 of 1,173) with videos related to
Sort By:
Page
of 118
Annals of Family Medicine
|
March 10, 2010
Patients' question-asking behavior during primary care visits: a report from the AAFP National Research Network
James M Galliher, Douglas M Post, Barry D Weiss, et al.
Plos One
|
June 19, 2015
Immunogens Modeling a Fusion-Intermediate Conformation of gp41 Elicit Antibodies to the Membrane Proximal External Region of the HIV Envelope Glycoprotein
Russell Vassell, Yong He, Prasad Vennakalanti, et al.
American Journal of Physical Medicine & Rehabilitation
|
October 15, 2019
The Vital Role of Professionalism in Physical Medicine and Rehabilitation
Julie K Silver, Sara Cuccurullo, Lyn D Weiss, et al.
Drug and Alcohol Dependence
|
April 12, 2008
Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders
Timothy E Wilens, Lenard A Adler, Margaret D Weiss, et al.
Metabolic Engineering
|
August 30, 2005
Metabolically engineered oilseed crops with enhanced seed tocopherol
Balasulojini Karunanandaa, Qungang Qi, Ming Hao, et al.
Plos One
|
April 5, 2022
Opioid-related overdose and chronic use following an initial prescription of hydrocodone versus oxycodone
Scott G Weiner, Michelle A Hendricks, Sanae El Ibrahimi, et al.
Leukemia
|
March 11, 2017
The CXCR4 inhibitor BL-8040 induces the apoptosis of AML blasts by downregulating ERK, BCL-2, MCL-1 and cyclin-D1 via altered miR-15a/16-1 expression
M Abraham, S Klein, B Bulvik, et al.
Psycho-Oncology
|
February 12, 2004
The talking touchscreen: a new approach to outcomes assessment in low literacy
Elizabeth A Hahn, David Cella, Deborah Dobrez, et al.
Journal of the American Academy of Child and Adolescent Psychiatry
|
August 23, 2007
High-dose atomoxetine treatment of ADHD in youths with limited response to standard doses
Christopher J Kratochvil, David Michelson, Jeffrey H Newcorn, et al.
Cancer Research
|
December 21, 2017
CXCR4 Promotes Neuroblastoma Growth and Therapeutic Resistance through miR-15a/16-1-Mediated ERK and BCL2/Cyclin D1 Pathways
Shiri Klein, Michal Abraham, Baruch Bulvik, et al.
Page
of 118